ChemicalBook > CAS DataBase List > Levobupivacaine hydrochloride

Levobupivacaine hydrochloride

Product Name
Levobupivacaine hydrochloride
CAS No.
27262-48-2
Chemical Name
Levobupivacaine hydrochloride
Synonyms
BUPIVACAINE HCL;(S)-Bupivacaine;LEVAMISOLHCLSALT;L-(-)-Bupivacaine;TIMTEC-BB SBB001337;LEVOBUPIVACAINE HCL;(S)-(-)-Bupivacaine;Levobupivacaine HCI;Bupivacaine Impurity 1;(S)-(-)-BUPIVACAINE HCL
CBNumber
CB3408801
Molecular Formula
C18H29ClN2O
Formula Weight
324.89
MOL File
27262-48-2.mol
More
Less

Levobupivacaine hydrochloride Property

Melting point:
254 °C (dec.)(lit.)
alpha 
-12.5 º (c=2, water)
storage temp. 
2-8°C
solubility 
H2O: soluble20mg/mL, clear
form 
powder
color 
white to beige
optical activity
[α]/D -10 to -14°, c = 1.0 in H2O
InChI
InChI=1/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H/t16-;/s3
InChIKey
SIEYLFHKZGLBNX-NTISSMGPSA-N
SMILES
C([C@@H]1CCCCN1CCCC)(=O)NC1C(=CC=CC=1C)C.Cl |&1:1,r|
CAS DataBase Reference
27262-48-2(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
T+,Xn
Risk Statements 
26/27/28-20/21/22-28
Safety Statements 
22-36/37/39-45-36/37-53
RIDADR 
UN 2811 6.1/PG 2
WGK Germany 
3
RTECS 
TK6125000
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML1092
Product name
Levobupivacaine hydrochloride
Purity
≥98% (HPLC)
Packaging
10mg
Price
$92.2
Updated
2024/03/01
Sigma-Aldrich
Product number
SML1092
Product name
Levobupivacaine hydrochloride
Purity
≥98% (HPLC)
Packaging
50mg
Price
$357
Updated
2024/03/01
Alfa Aesar
Product number
H37643
Product name
Levobupivacaine hydrochloride
Purity
98%
Packaging
250mg
Price
$148.05
Updated
2023/01/06
Alfa Aesar
Product number
H37643
Product name
Levobupivacaine hydrochloride
Purity
98%
Packaging
1g
Price
$438.9
Updated
2023/01/06
TRC
Product number
B689675
Product name
(S)-(-)-BupivacaineHydrochloride
Packaging
500mg
Price
$495
Updated
2021/12/16
More
Less

Levobupivacaine hydrochloride Chemical Properties,Usage,Production

Description

Levobupivacaine was first launched in the US for the production of local anesthesia for surgery and obstetrics and for post-operative pain management. It is the (S)-enantiomer of the long acting, highly potent local anesthetic bupivacaine (Marcaine) that can be prepared by a three step sequence from (S)-pipecolic acid or from (S)-lysine by oxidative deamination and stereospecific ring closure to (S)-pipecolamide core structure. Levobupivacaine exhibits its long-acting local anesthetic effect by blocking neuronal sodium channel ion flow in nerve axons. Clinical studies demonstrated an efficacy and a general profile closely resembling those of the racemic bupivacaine currently in use; however, it produced an enhanced safety profile, in particular substantially reduced (about one-third) cardiotoxicity (less effect on myocardial contractility and QT, prolongation) and CNS depressive side effects. Onset and duration of blockade were also equivalent or even better.

Chemical Properties

white crystalline powder

Originator

Chiroscience (UK)

Uses

Levobupivacaine hydrochloride has been used as an analyte in tandem mass spectrometry. It may be used to test its inhibitory effect on phosphorylation of extracellular signal-regulated kinase (ERK) mediated by capsaicin It may also be used as a component of poly(D,L-lactide-co-glycolide) (PLGA) microparticles for testing its sustainable release by electrospraying technique.

Definition

ChEBI: Levobupivacaine hydrochloride (anhydrous) is the monohydrochloride salt of levobupivacaine. It has a role as a local anaesthetic, an adrenergic antagonist, an amphiphile, an EC 3.1.1.8 (cholinesterase) inhibitor and an EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor. It contains a levobupivacaine(1+). It is an enantiomer of a dextrobupivacaine hydrochloride (anhydrous).

Manufacturing Process

Synthesis of L-pipecolic acid 2,6-xylidide (Patent US 4,695,576)
130 g of pipecolic acid and 158.6 g of Laevo (+)-tartaric acid are dissolved under stirring in 2 L 95% ethyl alcohol and 125 ml water at 80°C. The solution is allowed to cool to room temperature and after two days the crystallized D-pipecolic-tartrate is separated. The L-pipecolic-tartrate remains in solution. The filtrate is evaporated and dissolved in 5% acetic acid. Finally the solution is treated with Amberlite IR 45* in an ion exchanger. The eluate thus obtained is evaporated and the resulting crystalline residue is dried with potassium hydroxide in vacuo. The product obtained consists of L-pipecolic acid [α]D24 = -26.2°(C = 5, H2O).
4 g of phosphorus pentachloride was added to a suspension of 4 g of Lpipecolic acid hydrochloride in 40 ml acetylchloride. The initial reaction is effected at a temperature of about 35°C under stirring for 2 hours. The chlorination is completed by adding during a time period of about 10 minutes an additional two grams of phosphorus pentachloride and stirring over a further period of 4 hours while maintaining the suspension at a temperature of about 35°C. The resulting L-pipecolic acid chloride hydrochloride is filtered and washed with toluene and acetone. The crystalline residue is then dried in vacuo, m.p. 155°C.
A mixture of 2.7 ml 2,6-dimethylaniline, 4 ml acetone, and 4 ml Nmethylpyrrolidone is gradually added under stirring for 2 hours at 70°C to a suspension of 4 g of L-pipecolic acid chloride hydrochloride. This yields a crystalline product, which is filtered, washed with acetone and dried. This crystalline product is then dissolved in water and the base is precipitated by the addition of ammonia. The base is then extracted by the use of toluene and is recovered by evaporation. The base is recrystallized from a mixture of hexane and ethanol to yield L-pipecolic acid 2,6-xylidide. The melting point of this compound is 129-130°C.
Preparation of L-N-n-butylpipecilic acid 2,6-xylidide may de carried out by analogy with the preparation of L-N-n-propylpipecolic acid 2,6-xylidide (Patent US 5,777,124).
n-Butylbromide and potassium carbonate are added to a solution of L-pipecolic acid 2,6-xylidide dissolved in isopropyl alcohol. Thereafter, 5 ml of water is added to the mixture and the reaction is carried out for 4 hours at 72°C.
To complete the reaction, a further 0.8 ml n-butylbromide are added under continuous stirring and heating for 4 hours. The residue is treated with a mixture of 250 ml toluene and an equal amount of water at 50°C. The toluene layer is separated and washed three times with 100 ml warm water (40°C). A 175 ml portion of the toluene is removed by evaporation and the remainder is stored at +5°C for 6 hours to achieve crude crystalline L-N-n-butylpipecilic acid 2,6-xylidide. The crystalline product is separated by filtration, washed with some cooled toluene and dried at 70°C. Recrystallization may be carried from toluene. This product is dissolved in 100 ml ethanol and neutralized with concentrated hydrochloric acid. Ethanol is removed by evaporation and the hydrochloride product obtained is vacuum dried. Finally the latter is recrystallized from isopropyl alcohol.

brand name

Chirocaine (Purdue).

Therapeutic Function

Local anesthetic

Biological Functions

Levobupivacaine hydrochloride (Chirocaine) is the S-enantiomer of bupivacaine. It too has long action. Animal studies show that it has less CNS and cardiac toxicity than does bupivacaine. It also is slightly more motor sparing than is bupivacaine.

General Description

Levobupivacaine belongs to the N-alkyl substituted pipecoloxylidide family and comprises amino-amide group.

Biochem/physiol Actions

Levobupivacaine hydrochloride is a sodium channel blocker used as a long-acting local anaesthetic for epidural anesthesia. Levobupivacaine is the (S)-isomer of bupivacaine, with efficacy similar to that of bupivacaine with a reduced risk of cardiotoxicity.

Mode of action

Levobupivacaine Hydrochloride is the hydrochloride salt of levobupivacaine, an amide derivative with anesthetic property. Levobupivacaine reversibly binds voltage-gated sodium channels to modulate ionic flux and prevent the initiation and transmission of nerve impulses (stabilizing neuronal membrane), thereby resulting in analgesia and anesthesia. In comparison with racemic bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action.

Levobupivacaine hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

View Lastest Price from Levobupivacaine hydrochloride manufacturers

Wuhan Haorong Biotechnology Co.,Ltd
Product
Levobupivacaine hydrochloride 27262-48-2
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
500
Release date
2023-07-14
PNP Biotech Co. Ltd
Product
Levobupivacaine HCl 27262-48-2
Price
US $0.00/kg
Min. Order
25kg
Purity
98%
Supply Ability
Inquiry
Release date
2022-10-19
Shaanxi Franta Biotechnology Co., Ltd
Product
Levobupivacaine hydrochloride 27262-48-2
Price
US $20.00/kg
Min. Order
1kg
Purity
99
Supply Ability
1000kg
Release date
2024-03-27

27262-48-2, Levobupivacaine hydrochlorideRelated Search:


  • TIMTEC-BB SBB001337
  • (S)-(-)-BUPIVACAINE HCL
  • (S)-(-)-BUPIVACAINE HYDROCHLORIDE
  • (S)-(-)-1-N-BUTYL-2',6'-DIMETHYL-2-PIPERIDINCARBOXANILID HYDROCHLORIDE
  • (S)-(-)-1-BUTYL-2-(2,6-XYLYLCARBAMOYL)-PIPERIDINE HYDROCHLORIDE
  • s-(-)-1-butyl-2',6'-pipecoloxylidide hydrochloride
  • (s)-1-butyl-2’,6’-piperidinecarboxamidemonohydrochloride
  • (s)-1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamidemonohydrochloride
  • (S)-1-Butyl-N-(2,6-diMethylphenyl)piperidine-2-carboxaMide hydrochloride
  • (2S)-1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide, hydrochloride (1:1)
  • Levobupivacaine hydrochloride S-(-)-1-Butyl-2',6'-pipecoloxylidide hydrochloride
  • levobupivacaine hydrochloride (anhydrous)
  • Levobupivacaine hydrochloride 27262-48-2
  • A Ropivacaine Impurity A(EP)
  • Bupivacaine Impurity 1
  • Levobupivacaine HCL //Levobupivacaine
  • LEVAMISOLHCLSALT
  • (S)-(-)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride
  • 2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (-)
  • (S)-(-)-Bupivacaine hydrochloride,99%
  • 6’-pipecoloxylidide,1-butyl-,hydrochloride,(-)-2
  • bupicainehydrochloride(-)
  • BUPIVACAINE HYDROCHLORIDE, MONOHYDRATE
  • BUPIVACAINE HCL
  • LEVOBUPIVACAINE HCL
  • LEVOBUPIVACAINE HYDROCHLORIDE
  • L-BUPIVACAINE HYDROCHLORIDE
  • (S)-(-)-Bupivacaine monohydrochloride
  • (S)-(-)-BUPIVACAINEHYDROCHLORIDEMONOHYDRATE
  • (S)-(-)-Bupivacaine
  • (S)-Bupivacaine
  • 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-
  • 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (S)-
  • L-(-)-Bupivacaine
  • 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (2S)-
  • 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (S)-
  • Ropivacaine EP Impurity A HBr
  • (S)-Bupivacaine HCl (Levobupivacaine HCl)
  • Levobupivacaine hydrochloride USP/EP/BP
  • Levobupivacaine hydrochloride Impurities
  • Levobupivacaine HCl (S-Bupivacaine)
  • Levo-Bupivacaine hydrochlorideQ: What is Levo-Bupivacaine hydrochloride Q: What is the CAS Number of Levo-Bupivacaine hydrochloride
  • Ropivacaine Impurity A(EP)
  • Levobupivacaine HCI
  • Levobupivacaine hcl Anesthetic Raw Powder
  • API Levobupivacaine hydrochloride Powder Dosage Usage Effect and Benefit
  • 27262-48-2
  • 27626-48-2
  • 27626-47-1
  • 15252-80-3
  • C18H28N2OHCl
  • C18H29ClN2O
  • API
  • Inhibitors
  • Active Pharmaceutical Ingredients
  • Pharmaceutical Raw Materials
  • BDO